2014.05.30 | People news, PhD students, Dept Clin Epi
The Danish Agency for Science, Technology and Innovation has appointed professor Henrik Toft Sørensen from Department of Clinical Epidemiology as head of the Coordinating Body for Registry Research, KOR (In Danish: det Koordinerende Organ for Registerforskning (KOR)). The position is for a four-year period. KOR is a newly established advisory body…
2014.05.27 | Health, Health, Technical / administrative staff
The senior management team has decided that all AU employees should have an email address that reflects AU’s organisation. This means that approximately 80 percent of employees must change email address.
2014.05.27 | Aarhus University, External target group, Public/Media
Professor Marie Louise Stig Sørensen and Professor Ole E. Barndorff-Nielsen are each to receive the Rigmor and Carl Holst-Knudsen Award for Scientific Research 2014.
2014.05.27 | Health, Health, Academic staff
Tailored purchasing agreements, volume discounts and the appointment of local procurement managers will reduce the cost of procurement at Health. These are the expectations for a new pilot project.
2014.05.27 | Health, Health, Academic staff
Glucocorticoids, obesity and early life programming.
2014.05.27 | Health and disease, PhD defense, Health
Bronchoscopy Simulation Training. Exploring effective and efficient training methods for complex skills learning.
2014.05.27 | Health and disease, PhD defense, Health
Exposure to psychological and biological stress early in life and the development of body weight in the offspring, including overweight and obesity.
2014.05.26 | Health, Academic staff, Department of Clinical Medicine
Snip, snap, snude
2014.05.26 | PhD defense, Academic staff, Department of Clinical Medicine
Vasodilating antihypertensive therapy in chronic kidney disease - Effects on vascular resistance and renal oxygenation.
2014.05.27 | Aarhus University, External target group, All groups
Aarhus University has developed a technology that uses the HIV virus as a tool in the fight against hereditary diseases - and in the long term, against HIV infection as well. The technology repairs the genome in a new and safer manner.